13 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... drugs. ... pharmacology #dm2 #diabetes ... #medications #overview ... #management #comparison
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... pharmacotherapy #table #comparison ... #management #medications ... #diabetes #endocrinology
Diabetes Pathophysiology and Medication Targets

The ominous octet is one concept that summarizes the different pathophysiologic pathways
and Medication ... medications and ... Pathophysiology #Medication ... #Targets #Drug ... #Endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... EricsMedicalLectures/featured #diabetes ... #medications #table ... #comparison #management ... #endocrinology
Shock Classification and Differential Diagnosis
SHOCK
 • MAP <65, SBP <90, drop in SBP > 40
 •
Shock Classification ... High CO / Low SVR ... Failure, Toxins/Medications ... Sophia_Hayes_MD #Shock #Classification ... Diagnosis #Types #criticalcare
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... #Pharmacology #Medications ... #DM2 #Diabetes ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Type 2 Inpatient Medication ... DM2 #Inpatient #Medications ... #pharmacology #comparison ... #table #endocrinology
A toxidrome is a syndrome (set of symptoms) caused by specific medications or toxins.

There are 5
is a syndrome (set ... caused by specific medications ... barbituates, “Z-drugs ... Toxicology #Toxidromes #Comparison
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Inhibitors Increasing Indications ... Significant Adverse Drug ... #Euglycemic #Diabetic ... diagnosis #management #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
thing about this drug ... different than other medications ... This drug class ... Pharmacology #Management #Diabetes ... #DM2 #Endocrinology